definiens: , or means ( for the purposes of Clauses 13.2.1, 13.2.2, 14.4 and paragraph1.8 of Part B Schedule 9, paragraph 1.7 of Part C Schedule 9 and paragraph 1.7 of Part D Schedule 9 ) in thecase of a product or a therapy that such product or therapy would, were it not for the applicable licence grantedand subsisting hereunder, infringe the applicable Patent Rights so licensed hereunder ; means Cancer Research UK ( registered as a company limited by guarantee in England and Walesunder number 4325234 ) and registered charity ( number 1089464 in England and Wales and registered inScotland under number SC041666 and in the Isle of Man under number 1103 ) ; means Cancer Research Technology Limited, with company number 01626049 ( ), CRUK, Leukaemia and Lymphoma Research ( registered as a company limited by guarantee in England andWales under number 738089 and registered charity number 216032 in England and Wales and registered inScotland under number SC037529 ) ( ) and Kay Kendall Leukaemia Fund ( a registered charity in Englandand Wales with number 290772 ) ( ) ; has the meaning set out in Clause 23.1.1 ; has the meaning set out in Clause 11.1.1(ii ) ; has the meaning set out in Clause 24.4 ; or means those countries that are : ( a ) eligible for supportfrom [ * * * ] ; and ( b ) to the extent not included in ( a ), defined as at the Second Amendment Date by the [ * * * ], assuch definitions may be amended from time to time by the World Bank : has the meaning set out in Clause 29.7 ; has the meaning set out in Clause 20.1 ; has the meaning in Clause 5.2 ; has the meaning set out in Clause 19.2 ; means all uses and applications without restriction ; has the meaning set out in Clause 2.2.12 ; CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT . THE COPY FILEDHEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST . OMISSIONS AREDESIGNATED [ * * * ] . A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THESECURITIES AND EXCHANGE COMMISSION